DKK3 inhibits the Wnt/β-catenin pathway and acts as a tumor suppressor or oncogene [43], when upregulated in breast, ovarian, colon, and pancreas cancers, then it is associated with poor outcomes. The gene discussed is DKK3; the disease is pancreatic neoplasm.